BioCentury | Jan 31, 2020
Distillery Therapeutics

Crry gene therapy to treat multiple sclerosis

...of the complement inhibitor Crry at C3-bound synapses could treat MS. The AAV9 vector encodes Crry...
...of MS, the gene therapy prevented disease-associated losses in synapses and visual acuity. TARGET/MARKER/PATHWAY: Complement receptor-related protein (Crry...
BioCentury | Feb 14, 2011
Strategy

Alexion's expansions

...dry AMD. Taligen's TT32 , a CR2 fragment linked to the complement-inhibitory domain of complement receptor-related protein (Crry...
BioCentury | Oct 6, 2008
Clinical News

Taligen Therapeutics preclinical data

...2 (CR2) fragment linked to the complement inhibitory domain of complement receptor related protein ( Crry...
BioCentury | Oct 6, 2008
Clinical News

Taligen Therapeutics preclinical data

...2 (CR2) fragment linked to the complement inhibitory domain of complement receptor related protein ( Crry...
Items per page:
1 - 4 of 4